ORTHOVISC Shoulder Osteoarthritis Study

PHASE3CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

August 31, 2011

Conditions
Glenohumeral Osteoarthritis
Interventions
DEVICE

Orthovisc

Orthovisc injection

DRUG

Control

Celestone (betamethasone sodium phosphate and acetate) - 2 mL

Trial Locations (13)

10065

Insall Scott Kelly Institute, New York

11030

The Methodist, Houston

16801

University Orthopedics Center, State College

22908

University of Virginia, Charlottesville

32561

Andrews Research Institute, Gulf Breeze

33146

UHZ Sports Medicine, Coral Gables

48081

Shores Rheumatology, Saint Clair Shores

70121

Ochsner Clinic Foundation, New Orleans

74146

Tulsa Bone and Joint, Tulsa

92024

CORE Orthopedics, Encinitas

93720

Sierra Pacific Orthopaedic Center Medical Group, Fresno

98431

Madigan Army Medical Center, Tacoma

01605

University of Massachusetts Merdical School - Worcester, Worcester

All Listed Sponsors
lead

DePuy Mitek

INDUSTRY

NCT00436969 - ORTHOVISC Shoulder Osteoarthritis Study | Biotech Hunter | Biotech Hunter